ATI Exit Exam 2023

Correct Answer: C

Rationale: The correct answer is C, 'Serum creatinine 3.5 mg/dL.' An elevated serum creatinine level indicates worsening kidney function and impaired renal clearance, which should be reported to the provider promptly. Choice A, 'Blood urea nitrogen (BUN) 15 mg/dL,' is within the normal range (7-20 mg/dL) and does not indicate acute kidney injury. Choice B, 'Urine output of 45 mL/hr,' is a low urine output but does not directly reflect kidney function decline. Choice D, 'Calcium 9 mg/dL,' is within the normal calcium range (8.5-10.5 mg/dL) and is not specifically indicative of acute kidney injury.

Correct Answer: C

Rationale: The correct answer is C. Clients taking clopidogrel should take the medication with a full glass of water to prevent gastrointestinal irritation. Choice A is incorrect because there is no specific recommendation to avoid foods high in potassium with clopidogrel. Choice B is unrelated to the medication's administration. Choice D is a duplication of choice C, providing no additional information.

Correct Answer: C

Rationale: The correct answer is C. When a client understands the teaching about iron supplements, they should know that black, tarry stools are a normal side effect. This indicates that the medication is being absorbed and working effectively. Choices A and B are incorrect because iron supplements should not be taken with milk or orange juice, as these can interfere with the absorption of iron. Choice D is also incorrect because iron supplements are usually best absorbed on an empty stomach, so taking them before bedtime may not be ideal.

Correct Answer: B

Rationale: The correct answer is B. Rifampin can cause a harmless reddish-orange discoloration of body fluids, including urine. Choice A is not related to rifampin; vision changes are not a common side effect of the medication. Choice C is more relevant to medications that cause photosensitivity reactions, not specifically rifampin. Choice D is incorrect because nausea is a common side effect of rifampin, but it does not warrant immediate discontinuation of the medication.

Correct Answer: A

Rationale: The correct answer is A: 'A statement that participants can leave the study at will.' This information is crucial to include in the informed document to ensure that participants are aware of their right to withdraw from the study at any time without any negative consequences. Choice B is incorrect because participants should not be assigned to experimental or control groups without their knowledge and consent. Choice C is incorrect because disclosing a list of clients participating in the study violates confidentiality. Choice D is incorrect as the description of the data evaluation framework is important but not as critical as ensuring participants know they can leave the study at will.